European Biotech Acquisition Corp CEO Eduardo Bravo and Sanaby Health CEO Sandra Shpilberg

Tale of two SPACs: One strikes a deal as tur­bu­lent mar­ket forces an­oth­er to dis­solve

The SPAC mar­ket con­tin­ued its rough year Mon­day, as one blank check com­pa­ny is set to move for­ward on a deal while an­oth­er dis­solved. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.